LLY

800.11

+3.9%↑

UNH

605.2

+1.14%↑

JNJ

156.97

-0.71%↓

NVO

107.05

+1.34%↑

ABBV

200.3

-0.62%↓

LLY

800.11

+3.9%↑

UNH

605.2

+1.14%↑

JNJ

156.97

-0.71%↓

NVO

107.05

+1.34%↑

ABBV

200.3

-0.62%↓

LLY

800.11

+3.9%↑

UNH

605.2

+1.14%↑

JNJ

156.97

-0.71%↓

NVO

107.05

+1.34%↑

ABBV

200.3

-0.62%↓

LLY

800.11

+3.9%↑

UNH

605.2

+1.14%↑

JNJ

156.97

-0.71%↓

NVO

107.05

+1.34%↑

ABBV

200.3

-0.62%↓

LLY

800.11

+3.9%↑

UNH

605.2

+1.14%↑

JNJ

156.97

-0.71%↓

NVO

107.05

+1.34%↑

ABBV

200.3

-0.62%↓

Search

Amylyx Pharmaceuticals Inc

Avatud

6.74 13.47

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

5.92

Max

7.05

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-13.94 downside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. nov 2024

Amylyx Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. nov 2024, 23:28 UTC

Tulu

DBS Third-Quarter Net Beats Estimates; Plans Share Buyback

6. nov 2024, 22:28 UTC

Peamised uudised

Canada Orders TikTok Canada Unit to Dissolve Operations on National-Security Concerns

6. nov 2024, 22:25 UTC

Tulu

Gilead Sciences Post Higher 3Q Revenue, Raises Fiscal Year Guidance

6. nov 2024, 22:09 UTC

Tulu

NAB Raises Dividend Despite a 6.1% Fall in Annual Profit -- Update

6. nov 2024, 23:46 UTC

Tulu

Qualcomm Stock Jumps on Solid Earnings. Watch for These Risks. -- Barrons.com

6. nov 2024, 23:08 UTC

Tulu

Kakao 3Q Net Profit Missed FactSet-Compiled Consensus

6. nov 2024, 23:07 UTC

Tulu

Kakao Corp. 3Q Net KRW78.51B Vs. Net KRW36.86B >035720.SE

6. nov 2024, 23:07 UTC

Tulu

Kakao Corp. 3Q Oper Pft KRW130.53B Vs. Pft KRW124.31B >035720.SE

6. nov 2024, 23:07 UTC

Tulu

Kakao Corp. 3Q Rev KRW1.921T Vs. KRW2.011T >035720.SE

6. nov 2024, 23:05 UTC

Tulu

Franco-Nevada 3Q EPS 79c >FNV

6. nov 2024, 23:05 UTC

Tulu

Franco-Nevada 3Q Rev $275.7M >FNV

6. nov 2024, 23:03 UTC

Tulu

APA 3Q Rev $2.54B >APA

6. nov 2024, 23:03 UTC

Tulu

APA 3Q Loss/Shr 60c >APA

6. nov 2024, 22:47 UTC

Tulu

DBS Board Sets Up S$3.0B Share-Buyback Program >D05.SG

6. nov 2024, 22:45 UTC

Tulu

DBS Declares 3Q Dividend of S$0.54 >D05.SG

6. nov 2024, 22:44 UTC

Tulu

DBS 3Q Net Interest Income S$3.80B Vs. S$3.68B >D05.SG

6. nov 2024, 22:44 UTC

Tulu

DBS 3Q Net S$3.03B Vs. Net S$2.63B >D05.SG

6. nov 2024, 22:44 UTC

Tulu

DBS 3Q Total Income S$5.75B Vs. S$5.19B >D05.SG

6. nov 2024, 22:34 UTC

Tulu

Nutrien 3Q Sales $5.35B >NTR.T

6. nov 2024, 22:34 UTC

Tulu

Nutrien 3Q EPS 4c >NTR.T

6. nov 2024, 22:24 UTC

Peamised uudised

Stocks Soar, Dollar Jumps as Trump's Win Reverberates Through Markets -- Update

6. nov 2024, 22:17 UTC

Tulu

Arm Delivers Beat-And-Raise Report But Keeps Full-Year Outlook Unchanged -- IBD

6. nov 2024, 22:10 UTC

Tulu

Gilead Sciences Post Higher 3Q Revenue, Raises FY Guidance

6. nov 2024, 22:09 UTC

Market Talk
Tulu

Take-Two Boss Is Eying Microsoft's Strategy With 'Call of Duty' -- Market Talk

6. nov 2024, 22:09 UTC

Tulu

Manulife 3Q Net C$1.8B >MFC

6. nov 2024, 22:09 UTC

Tulu

Manulife 3Q EPS C$1.00 >MFC

6. nov 2024, 22:07 UTC

Tulu

Ashland 4Q EPS 39c >ASH

6. nov 2024, 22:07 UTC

Tulu

Ashland 4Q Sales $522M >ASH

6. nov 2024, 22:07 UTC

Tulu

Ashland Sees FY25 Sales $1.90B-$2.05B >ASH

6. nov 2024, 22:03 UTC

Market Talk

Global Equities Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Amylyx Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

-13.94% langus

12 kuu keskmine prognoos

Keskmine 5 USD  -13.94%

Kõrge 8 USD

Madal 3 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Amylyx Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

2

Osta

3

Hoia

0

Müü

Finantsandmed

$